SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-14-003779
Filing Date
2014-09-09
Accepted
2014-09-09 16:11:45
Documents
4

Document Format Files

Seq Description Document Type Size
1 SUPERNUS PHARMACEUTICALS, INC. p14-1899sc13da.htm SC 13D/A 33057
2 EXHIBIT A p14-1899exhibita.htm EX-99 4087
3 EXHIBIT B p14-1899exhibit_b.htm EX-99 27029
4 GRAPHIC image_002.jpg GRAPHIC 21578
  Complete submission text file 0000902664-14-003779.txt   95499
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Subject) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-86843 | Film No.: 141093473
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W. 57TH STREET 41ST FLOOR NEW YORK NY 10019
Business Address 152 W. 57TH STREET 41ST FLOOR NEW YORK NY 10019 212-521-1150
Orchard Hill Capital Management LP (Filed by) CIK: 0001565989 (see all company filings)

IRS No.: 010936280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A